Trader Qiagen NV - QIA CFD
Ajouter aux favoris- Résumé
- Données historiques
- Événements
- Compte de résultat
- Bilan
- Flux de trésorerie
- Capital
Écart | 0.140 | ||||||||
Frais de position longue en overnight
Long position overnight fee
Aller vers la plateforme | -0.017913% | ||||||||
Frais de position courte en overnight
Short position overnight fee
Aller vers la plateforme | -0.004309% | ||||||||
Durée des frais en overnight | 21:00 (UTC) | ||||||||
Quantité minimale négociée | 1 | ||||||||
Devise | EUR | ||||||||
Marge | 20% | ||||||||
Bourse | Germany | ||||||||
Commission sur la négociation | 0% |
*Information provided by Capital.com
Qiagen NV ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Fermeture précédente* | 42.63 |
Ouvert* | 42.46 |
Variation sur 1 an* | -4.5% |
Fourchette du jour* | 42.46 - 42.75 |
Fourchette sur 52 semaines | 40.38-51.18 |
Volume moyen (10 jours) | 749.39K |
Volume moyen (3 mois) | 13.38M |
Capitalisation boursière | 10.50B |
Ratio C/B | 25.08 |
Actions en circulation | 227.72M |
Revenu | 2.14B |
EPS | 1.84 |
Dividende (rendement en %) | N/A |
Bêta | 0.39 |
Prochaine date de publication des résultats | Apr 24, 2023 |
Toutes les données sont fournies par Refinitiv, à l'exception des données marquées d'un astérisque, qui sont des *données fournies par Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Clôture | Change | Change (%) | Ouverture | High | Low |
---|---|---|---|---|---|---|
Mar 20, 2023 | 42.630 | -0.420 | -0.98% | 43.050 | 43.330 | 42.550 |
Mar 17, 2023 | 43.180 | 0.080 | 0.19% | 43.100 | 44.000 | 43.080 |
Mar 16, 2023 | 43.720 | -0.030 | -0.07% | 43.750 | 43.890 | 43.180 |
Mar 15, 2023 | 43.190 | 0.250 | 0.58% | 42.940 | 43.440 | 42.420 |
Mar 14, 2023 | 42.960 | -0.400 | -0.92% | 43.360 | 43.580 | 42.180 |
Mar 13, 2023 | 43.240 | 0.060 | 0.14% | 43.180 | 43.680 | 43.180 |
Mar 10, 2023 | 43.500 | 0.280 | 0.65% | 43.220 | 43.930 | 43.220 |
Mar 9, 2023 | 43.710 | 0.490 | 1.13% | 43.220 | 43.800 | 43.210 |
Mar 8, 2023 | 43.620 | 0.260 | 0.60% | 43.360 | 43.710 | 43.280 |
Mar 7, 2023 | 43.790 | -0.060 | -0.14% | 43.850 | 44.260 | 43.700 |
Mar 6, 2023 | 43.570 | 0.240 | 0.55% | 43.330 | 43.790 | 43.210 |
Mar 3, 2023 | 43.420 | 0.230 | 0.53% | 43.190 | 43.500 | 43.070 |
Mar 2, 2023 | 42.890 | 0.320 | 0.75% | 42.570 | 43.030 | 42.360 |
Mar 1, 2023 | 42.630 | -0.950 | -2.18% | 43.580 | 43.580 | 42.560 |
Feb 28, 2023 | 43.570 | -0.030 | -0.07% | 43.600 | 43.740 | 43.310 |
Feb 27, 2023 | 43.890 | -0.030 | -0.07% | 43.920 | 43.970 | 43.420 |
Feb 24, 2023 | 43.720 | -0.200 | -0.46% | 43.920 | 44.150 | 43.550 |
Feb 23, 2023 | 43.900 | -0.020 | -0.05% | 43.920 | 44.100 | 43.670 |
Feb 22, 2023 | 43.850 | -0.610 | -1.37% | 44.460 | 44.520 | 43.720 |
Feb 21, 2023 | 44.320 | 0.110 | 0.25% | 44.210 | 44.590 | 43.700 |
Qiagen NV Events
Heure (UTC) (UTC) | Pays | Événement |
---|---|---|
No events scheduled |
- Annuel
- Trimestriel
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Revenu total | 1337.99 | 1417.54 | 1501.85 | 1526.42 | 1870.35 | 2251.66 |
Revenu | 1337.99 | 1417.54 | 1501.85 | 1526.42 | 1870.35 | 2251.66 |
Coût des recettes, total | 481.378 | 493.596 | 499.271 | 521.162 | 637.631 | 800.837 |
Résultat brut | 856.613 | 923.94 | 1002.58 | 1005.26 | 1232.71 | 1450.82 |
Total des frais d'exploitation | 1250.11 | 1264.12 | 1235.27 | 1547.76 | 1483.92 | 1621.57 |
Total des frais de vente/Généraux/Admin | 500.765 | 511.999 | 508.146 | 505.268 | 525.362 | 584.468 |
Recherche et développement | 149.777 | 154.084 | 161.852 | 157.448 | 149.072 | 189.964 |
Depreciation / Amortization | 39.091 | 39.398 | 39.032 | 29.973 | 20.811 | 18.542 |
Charges (revenus) inhabituelles | 79.099 | 65.04 | 26.966 | 333.91 | 151.039 | 27.762 |
Produits d'exploitation | 87.881 | 153.419 | 266.581 | -21.337 | 386.431 | 630.084 |
Produits (charges) d'intérêts, nets Hors exploitation | -40.13 | -27.853 | -70.168 | -43.696 | -59.918 | -5.122 |
Autres, nets | 9.157 | -11.191 | 29.324 | -12.743 | 112.959 | 0.871 |
Résultat net avant impôts | 56.908 | 114.375 | 225.737 | -77.776 | 439.472 | 625.833 |
Résultat net après impôts | 80.303 | -20.406 | 190.38 | -41.455 | 359.188 | 512.599 |
Intérêts minoritaires | 0.101 | 0 | 0 | |||
Résultat net avant éléments extra | 80.404 | -20.406 | 190.38 | -41.455 | 359.188 | 512.599 |
Résultat net | 80.404 | 40.394 | 190.38 | -41.455 | 359.188 | 512.599 |
Revenu disponible pour les actionnaires ordinaires, hors éléments exceptionnels | 80.404 | -20.406 | 190.38 | -41.455 | 359.188 | 512.599 |
Bénéfice disponible pour les actionnaires ordinaires, y compris les éléments exceptionnels | 80.404 | 40.394 | 190.38 | -41.455 | 359.188 | 512.599 |
Ajustement pour dilution | 0 | 0 | 0 | |||
Résultat net dilué | 80.404 | 40.394 | 190.38 | -41.455 | 359.188 | 512.599 |
Moyenne pondérée des actions diluées | 230.142 | 228.074 | 233.456 | 226.777 | 234.214 | 232.034 |
BPA dilué hors éléments extraordinaires | 0.34937 | -0.08947 | 0.81549 | -0.1828 | 1.53359 | 2.20915 |
BPA dilué normalisé | 0.57277 | 0.09589 | 0.9129 | 0.77427 | 2.00343 | 2.30715 |
Total des éléments extraordinaires | 60.8 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Revenu total | 567.206 | 567.308 | 534.745 | 582.398 | 628.391 |
Revenu | 567.206 | 567.308 | 534.745 | 582.398 | 628.391 |
Coût des recettes, total | 196.615 | 198.12 | 197.528 | 208.574 | 213.421 |
Résultat brut | 370.591 | 369.188 | 337.217 | 373.824 | 414.97 |
Total des frais d'exploitation | 403.408 | 406.037 | 402.871 | 409.257 | 421.32 |
Total des frais de vente/Généraux/Admin | 147.563 | 141.412 | 143.219 | 152.274 | 152.854 |
Recherche et développement | 47.433 | 52.15 | 48.268 | 42.113 | 46.376 |
Depreciation / Amortization | 5.408 | 5.32 | 4.469 | 3.345 | 2.917 |
Charges (revenus) inhabituelles | 6.389 | 9.035 | 9.387 | 2.951 | 5.752 |
Produits d'exploitation | 163.798 | 161.271 | 131.874 | 173.141 | 207.071 |
Produits (charges) d'intérêts, nets Hors exploitation | -4.42 | -9.254 | 24.387 | -7.275 | -11.414 |
Autres, nets | -0.278 | -2.118 | -4.806 | -0.487 | -0.135 |
Résultat net avant impôts | 159.1 | 149.899 | 151.455 | 165.379 | 195.522 |
Résultat net après impôts | 129.223 | 121.051 | 133.139 | 129.186 | 155.312 |
Résultat net avant éléments extra | 129.223 | 121.051 | 133.139 | 129.186 | 155.312 |
Résultat net | 129.223 | 121.051 | 133.139 | 129.186 | 155.312 |
Revenu disponible pour les actionnaires ordinaires, hors éléments exceptionnels | 129.223 | 121.051 | 133.139 | 129.186 | 155.312 |
Bénéfice disponible pour les actionnaires ordinaires, y compris les éléments exceptionnels | 129.223 | 121.051 | 133.139 | 129.186 | 155.312 |
Résultat net dilué | 129.223 | 121.051 | 133.139 | 129.186 | 155.312 |
Moyenne pondérée des actions diluées | 232.309 | 231.95 | 232.129 | 231.761 | 230.164 |
BPA dilué hors éléments extraordinaires | 0.55625 | 0.52188 | 0.57356 | 0.55741 | 0.67479 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
BPA dilué normalisé | 0.57859 | 0.55334 | 0.6091 | 0.56736 | 0.69464 |
- Annuel
- Trimestriel
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total de l'actif à court terme | 1037.57 | 1647.97 | 2155.06 | 1570.25 | 1624.41 | 2109.6 |
Espèces et placements à court terme | 439.18 | 657.714 | 1393.69 | 753.233 | 715.233 | 1065.3 |
Cash | 137.615 | 139.597 | 208.083 | 189.569 | 245.373 | 235.381 |
Investissements à court terme | 301.565 | 518.117 | 1185.6 | 563.664 | 117.249 | 184.785 |
Total des créances, nettes | 420.922 | 761.617 | 422.091 | 484.608 | 486.605 | 469.663 |
Accounts Receivable - Trade, Net | 278.244 | 329.138 | 351.612 | 385.117 | 389.058 | 376.213 |
Total Inventory | 136.552 | 155.927 | 162.912 | 170.704 | 291.181 | 327.525 |
Prepaid Expenses | 35.529 | 41.775 | 48.25 | 45.409 | 61.159 | 60.629 |
Other Current Assets, Total | 5.386 | 30.94 | 128.122 | 116.294 | 70.227 | 186.484 |
Total Assets | 4308.19 | 5038.52 | 5748.33 | 5235.62 | 5869.62 | 6146.95 |
Property/Plant/Equipment, Total - Net | 436.655 | 494.321 | 511.659 | 455.243 | 661.894 | 739.077 |
Property/Plant/Equipment, Total - Gross | 887.815 | 1058.91 | 1115.09 | 1154.37 | 1292.34 | 1371.49 |
Accumulated Depreciation, Total | -451.16 | -564.588 | -603.43 | -699.13 | -630.443 | -632.416 |
Goodwill, Net | 1925.52 | 2012.9 | 2108.54 | 2140.5 | 2364.03 | 2350.76 |
Intangibles, Net | 557.159 | 499.318 | 475.043 | 632.434 | 726.194 | 627.436 |
Other Long Term Assets, Total | 351.293 | 328.7 | 437.434 | 356.488 | 488.995 | 294.676 |
Total Current Liabilities | 308.429 | 324.792 | 972.189 | 951.345 | 572.175 | 1517.47 |
Accounts Payable | 51.218 | 59.205 | 69.415 | 84.767 | 118.153 | 101.224 |
Accrued Expenses | 144.014 | 173.307 | 209.748 | 332.151 | 220.755 | 219.936 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0.999 | 1.359 | 503.177 | 285.244 | 42.539 | 847.626 |
Other Current Liabilities, Total | 112.198 | 90.921 | 189.849 | 249.183 | 190.728 | 348.684 |
Total Liabilities | 1701.1 | 2497.52 | 3113.36 | 2699.02 | 3071.78 | 3050.4 |
Total Long Term Debt | 1067.1 | 1758.26 | 1671.09 | 1421.11 | 1880.21 | 1094.14 |
Long Term Debt | 1067.1 | 1758.26 | 1671.09 | 1421.11 | 1880.21 | 1094.14 |
Deferred Income Tax | 40.621 | 76.727 | 63.411 | 23.442 | 39.216 | 37.591 |
Minority Interest | 0 | |||||
Other Liabilities, Total | 284.952 | 337.743 | 406.672 | 303.13 | 580.179 | 401.199 |
Total Equity | 2607.1 | 2541 | 2634.97 | 2536.59 | 2797.84 | 3096.55 |
Common Stock | 2.812 | 2.702 | 2.702 | 2.702 | 2.702 | 2.702 |
Additional Paid-In Capital | 1794.67 | 1630.09 | 1742.19 | 1777.02 | 1834.17 | 1818.51 |
Retained Earnings (Accumulated Deficit) | 1263.46 | 1247.94 | 1379.62 | 1178.46 | 1323.09 | 1791.74 |
Treasury Stock - Common | -120.006 | -118.987 | -178.903 | -111.966 | -118.301 | -189.73 |
Unrealized Gain (Loss) | -0.156 | -0.942 | 0 | |||
Other Equity, Total | -333.683 | -219.817 | -310.644 | -309.619 | -243.822 | -326.67 |
Total Liabilities & Shareholders’ Equity | 4308.19 | 5038.52 | 5748.33 | 5235.62 | 5869.62 | 6146.95 |
Total Common Shares Outstanding | 225.873 | 226.557 | 225.509 | 227.752 | 227.985 | 227.074 |
Long Term Investments | 41.1 | 60.6 | 80.7 | 4.1 | 25.4 | |
Note Receivable - Long Term | 14.2 | |||||
Trésorerie et équivalents | 352.611 | 645.135 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Total de l'actif à court terme | 1665.55 | 1802.19 | 2028.4 | 2109.6 | 2097.25 |
Espèces et placements à court terme | 791.732 | 898.021 | 957.318 | 1065.3 | 1229.8 |
Trésorerie et équivalents | 787.786 | 759.047 | 617.541 | 880.516 | 770.515 |
Investissements à court terme | 3.946 | 138.974 | 339.777 | 184.785 | 459.285 |
Total des créances, nettes | 371.694 | 366.151 | 373.62 | 376.213 | 386.683 |
Accounts Receivable - Trade, Net | 371.694 | 366.151 | 372.22 | 376.213 | 386.683 |
Total Inventory | 316.28 | 341.041 | 335.691 | 327.525 | 321.621 |
Prepaid Expenses | 185.844 | 196.982 | 361.767 | 165.279 | 159.147 |
Total Assets | 5762.61 | 5907.48 | 6043.43 | 6146.95 | 6184.28 |
Property/Plant/Equipment, Total - Net | 563.917 | 599.991 | 612.114 | 739.077 | 638.225 |
Property/Plant/Equipment, Total - Gross | 1186.38 | 1245.04 | 1245.82 | 1270.6 | 1244.08 |
Accumulated Depreciation, Total | -622.464 | -645.05 | -633.706 | -632.416 | -605.858 |
Goodwill, Net | 2335.27 | 2332.7 | 2353.91 | 2350.76 | 2346.74 |
Intangibles, Net | 695.937 | 667.273 | 638.786 | 627.436 | 607.738 |
Long Term Investments | 17.1 | 21.5 | 19.5 | 25.4 | 26.6 |
Other Long Term Assets, Total | 484.836 | 483.821 | 390.72 | 294.676 | 467.728 |
Total Current Liabilities | 499.384 | 503.117 | 1070.03 | 1517.47 | 957.283 |
Accounts Payable | 103.471 | 103.004 | 94.265 | 101.224 | 87.012 |
Accrued Expenses | 335.713 | 325.813 | 571.229 | 568.62 | 335.279 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0 | 371.637 | 847.626 | 468.792 |
Other Current Liabilities, Total | 60.2 | 74.3 | 32.9 | 66.2 | |
Total Liabilities | 2912.83 | 2929.6 | 3029.69 | 3050.4 | 2944.14 |
Total Long Term Debt | 1928.95 | 1939.71 | 1568.66 | 1094.14 | 1474.9 |
Long Term Debt | 1928.95 | 1939.71 | 1568.66 | 1094.14 | 1474.9 |
Deferred Income Tax | 10.146 | 22.824 | 22.102 | 37.591 | 36.921 |
Other Liabilities, Total | 474.353 | 463.951 | 368.9 | 401.199 | 475.038 |
Total Equity | 2849.78 | 2977.87 | 3013.74 | 3096.55 | 3240.14 |
Common Stock | 2.702 | 2.702 | 2.702 | 2.702 | 2.702 |
Additional Paid-In Capital | 1789.81 | 1799.41 | 1811.54 | 1818.51 | 1830.59 |
Retained Earnings (Accumulated Deficit) | 1430.53 | 1537.48 | 1665.67 | 1791.74 | 1913.66 |
Treasury Stock - Common | -107.014 | -100.763 | -174.565 | -189.73 | -172.993 |
Other Equity, Total | -266.245 | -260.966 | -291.601 | -326.67 | -333.822 |
Total Liabilities & Shareholders’ Equity | 5762.61 | 5907.48 | 6043.43 | 6146.95 | 6184.28 |
Total Common Shares Outstanding | 228.407 | 228.638 | 227.336 | 227.074 | 227.452 |
Other Current Assets, Total | 175.284 |
- Annuel
- Trimestriel
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Revenu net/Ligne de départ | 80.303 | 40.394 | 190.38 | -41.455 | 359.188 | 512.599 |
Liquidités provenant des activités d'exploitation | 341.602 | 286.779 | 359.496 | 330.843 | 457.806 | 639.001 |
Liquidités provenant des activités d'exploitation | 213.056 | 216.448 | 206.436 | 231.458 | 205.014 | 214.931 |
Deferred Taxes | -65.974 | 60.176 | -23.272 | -55.362 | -6.706 | -5.288 |
Éléments non monétaires | 103.93 | 57.617 | 81.111 | 240.526 | -27.423 | 46.771 |
Cash Taxes Paid | 22.67 | 40.499 | 29.317 | 41.474 | 42.572 | 102.083 |
Intérêts payés en espèces | 18.227 | 20.252 | 25.902 | 29.721 | 25.351 | 21.588 |
Variation du fonds de roulement | 10.287 | -87.856 | -95.159 | -44.324 | -72.267 | -130.012 |
Flux de trésorerie liés aux activités d'investissement | -179.056 | -464.264 | -211.356 | -222.278 | -443.281 | -202.426 |
Dépenses d'investissement | -93.924 | -124.405 | -150.763 | -274.884 | -304.237 | -206.534 |
Autres éléments de flux de trésorerie d'investissement, total | -85.132 | -339.859 | -60.593 | 52.606 | -139.044 | 4.108 |
Flux de trésorerie provenant des activités de financement | -10.604 | 387.187 | 360.408 | -639.08 | -50.127 | -150.366 |
Éléments de flux de trésorerie de financement | -8.813 | -8.587 | -8.019 | -61.279 | -23.451 | -16.953 |
Émission (remboursement) d'actions, nette | 6.269 | -253.444 | -27.867 | 62.362 | 8.876 | -92.068 |
Émission (remboursement) de la dette, nette | -8.06 | 649.218 | 396.294 | -640.163 | -35.552 | -41.345 |
Effets de change | -2.773 | 8.832 | -7.183 | 0.826 | 4.196 | -3.677 |
Variation nette de la trésorerie | 149.169 | 218.534 | 501.365 | -529.689 | -31.406 | 282.532 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 129.223 | 250.274 | 383.413 | 512.599 | 155.312 |
Cash From Operating Activities | 128.627 | 285.026 | 440.543 | 639.001 | 207.41 |
Cash From Operating Activities | 55.587 | 110.669 | 163.83 | 214.931 | 52.998 |
Deferred Taxes | -28.396 | -30.993 | -29.394 | -5.288 | 0.615 |
Non-Cash Items | 12.034 | 40.196 | 35.251 | 46.771 | 21.86 |
Changes in Working Capital | -39.821 | -85.12 | -112.557 | -130.012 | -23.375 |
Cash From Investing Activities | 105.975 | -78.682 | -297.717 | -202.426 | -306.252 |
Capital Expenditures | -54.959 | -101.254 | -152.531 | -206.534 | -38.415 |
Other Investing Cash Flow Items, Total | 160.934 | 22.572 | -145.186 | 4.108 | -267.837 |
Cash From Financing Activities | -40.852 | -43.478 | -119.397 | -150.366 | -10.658 |
Financing Cash Flow Items | -2.017 | -4.847 | -3.625 | -16.953 | -10.687 |
Issuance (Retirement) of Stock, Net | 2.51 | 2.714 | -74.427 | -92.068 | 0.029 |
Issuance (Retirement) of Debt, Net | -41.345 | -41.345 | -41.345 | -41.345 | 0 |
Foreign Exchange Effects | -3.948 | -1.803 | -3.872 | -3.677 | -0.501 |
Net Change in Cash | 189.802 | 161.063 | 19.557 | 282.532 | -110.001 |
Nom de l'investisseur | Catégorie de l'investisseur | Pourcentage de l'encours | Actions détenues | Changement d'actions | Date d'avoirs | Taux du chiffre d'affaires |
---|---|---|---|---|---|---|
MFS Investment Management | Investment Advisor/Hedge Fund | 8.6971 | 19804737 | 392074 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.6439 | 8297775 | 129513 | 2022-12-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.5214 | 5741604 | 932553 | 2022-12-31 | LOW |
Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 2.4157 | 5500907 | 100754 | 2022-12-31 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.9693 | 4484423 | 201234 | 2022-12-31 | LOW |
J O Hambro Capital Management Limited | Investment Advisor/Hedge Fund | 1.8894 | 4302433 | -955906 | 2022-12-31 | LOW |
UBS Asset Management (Switzerland) | Investment Advisor | 1.8793 | 4279398 | 765282 | 2022-12-19 | LOW |
Arrowstreet Capital, Limited Partnership | Investment Advisor/Hedge Fund | 1.625 | 3700311 | 215475 | 2022-12-31 | MED |
Capital World Investors | Investment Advisor | 1.6138 | 3674825 | 0 | 2022-12-31 | LOW |
BlackRock Asset Management Deutschland AG | Investment Advisor | 1.3725 | 3125386 | 101378 | 2023-02-28 | LOW |
Schroder Investment Management Ltd. (SIM) | Investment Advisor/Hedge Fund | 1.3706 | 3120999 | 0 | 2023-01-31 | LOW |
Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 1.1858 | 2700209 | -568539 | 2022-12-31 | MED |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 1.141 | 2598279 | -510278 | 2022-12-31 | LOW |
Fidelity International | Investment Advisor | 0.9847 | 2242311 | 85153 | 2022-12-31 | LOW |
Marshall Wace LLP | Investment Advisor/Hedge Fund | 0.9721 | 2213542 | -138096 | 2022-12-31 | HIGH |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.9392 | 2138763 | -104054 | 2022-12-31 | LOW |
BofA Global Research (US) | Research Firm | 0.9294 | 2116389 | -914109 | 2022-12-31 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.9046 | 2060006 | 265911 | 2022-12-31 | LOW |
Davidson Kempner Capital Management LP | Hedge Fund | 0.8948 | 2037709 | -61957 | 2022-12-31 | HIGH |
Morgan Stanley & Co. LLC | Research Firm | 0.8507 | 1937191 | 116735 | 2022-12-31 | MED |
Pourquoi choisir capital.com? Nos chiffres parlent d'eux-mêmes.
Capital.com GroupTradeurs
Clients actifs par mois
Volume d'investissement par mois
Retrait par mois
Trading calculator
Calculez votre P&L hypothétique si vous aviez ouvert une transaction CFD à une certaine date (sélectionnez une date) et l'aviez fermée à une autre date (sélectionnez une date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Qiagen Company profile
À propos de Qiagen NV
Qiagen N.V. est une société de portefeuille. La Société et ses filiales sont spécialisées dans la fourniture de solutions Sample to Insight qui transforment les échantillons biologiques en aperçus moléculaires. Les solutions Sample to Insight incluent des technologies d'échantillon et d'analyse et des systèmes bioinformatique et d'automatisation. Ses solutions de bioinformatique interprètent des données pour fournir des informations privilégiées qui facilitent la prise de décision. Ses plates-formes d'automatisation rassemblent ces technologies au sein du flux de travail qui va des échantillons aux analyses. Ses technologies moléculaires Sample to Insight s'appliquent à un éventail d'applications et de catégories de clients sur plus de 500 produits consommables de base, ainsi qu'aux instruments qui automatisent l'utilisation de ces produits pour la préparation, l'analyse et l'interprétation de l'échantillon. Ses solutions de bioinformatique connectent les flux de travail de laboratoire et des quantités de processus de données génomiques qui facilitent la prise de décision des chercheurs ou des cliniciens quant à la suite des événements. Elle propose des solutions de diagnostic moléculaire, des tests appliqués, à l'industrie pharmaceutiques et au monde universitaire.
- IndustrieBiotechnology / Medical Research
- AdresseHulsterweg 82, VENLO, Netherlands (NLD)
- Employés6028
- CEOLawrence Rosen
Industry: | Biotechnology & Medical Research (NEC) |
Hulsterweg 82
VENLO
LIMBURG 5912 PL
NL
Compte de résultat
- Annual
- Quarterly
Les gens regardent aussi
Êtes-vous toujours à la recherche d'un broker de confiance?
Rejoignez les plus de 500 000 traders du monde entier qui ont choisi de trader avec Capital.com